Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Pichon

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Reproductive Immunology|December 1, 1989
Lymphocytic progesterone receptors in normal and pathological human pregnancyJ Szekeres-Bartho, M F Reznikoff-Etievant, P Varga, et al.
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
European Urology|August 31, 2001
Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinomaP Blanchet, S Droupy, P Eschwege, et al.
DNA (Mary Ann Liebert, Inc.)|February 1, 1985
Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cellsJ F Prud'homme, F Fridlansky, M Le Cunff, et al.
Clinical Breast Cancer|March 20, 2002
Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomographyA P Pecking, C Mechelany-Corone, F Bertrand-Kermorgant, et al.
Cancer Research|August 1, 1986
Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter studyG Leclercq, H Bojar, J Goussard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric studyJ M Riedinger, J Wafflart, G Ricolleau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2007
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcomeJ M Riedinger, F Bonnetain, J P Basuyau, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer|June 1, 1996
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancersM F Pichon, P Broet, H Magdelenat, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Reproductive Immunology|December 1, 1989
Lymphocytic progesterone receptors in normal and pathological human pregnancyJ Szekeres-Bartho, M F Reznikoff-Etievant, P Varga, et al.
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
European Urology|August 31, 2001
Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinomaP Blanchet, S Droupy, P Eschwege, et al.
DNA (Mary Ann Liebert, Inc.)|February 1, 1985
Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cellsJ F Prud'homme, F Fridlansky, M Le Cunff, et al.
Clinical Breast Cancer|March 20, 2002
Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomographyA P Pecking, C Mechelany-Corone, F Bertrand-Kermorgant, et al.
Cancer Research|August 1, 1986
Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter studyG Leclercq, H Bojar, J Goussard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric studyJ M Riedinger, J Wafflart, G Ricolleau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2007
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcomeJ M Riedinger, F Bonnetain, J P Basuyau, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer|June 1, 1996
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancersM F Pichon, P Broet, H Magdelenat, et al.
Pageof 5